ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

OPGN OpGen Inc

0.449
-0.086 (-16.07%)
2024年5月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
OpGen Inc OPGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.086 -16.07% 0.449 08:44:30
始値 安値 高値 終値 前日終値
0.50 0.4026 0.50 0.403 0.535
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3005:05GLOBEOpGen Provides Update on Business Operations and Strategic..
2024/4/2405:15GLOBEOpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
2024/3/2705:20APSShares Rip In Reaction To Activist Investor Becoming CEO
2024/3/2605:05GLOBEOpGen Announces Acquisition of Preferred Stock by David..
2024/2/1406:30EDGAR2Form 8-K - Current report
2024/2/0821:30EDGAR2Form 8-K - Current report
2024/1/1006:30EDGAR2Form 8-K - Current report
2023/12/1306:58EDGAR2Form 8-K - Current report
2023/12/0606:37EDGAR2Form 8-K - Current report
2023/11/2414:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1506:30GLOBEOpGen Reports Third Quarter 2023 Financial Results and..
2023/11/1406:59EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0806:30EDGAR2Form 8-K - Current report
2023/10/2705:30EDGAR2Form 8-K - Current report
2023/10/1705:30EDGAR2Form 8-K - Current report
2023/10/1406:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1406:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/1406:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1406:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1406:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1301:32GLOBEOpGen Enters Into Warrant Inducement Transaction for up to..
2023/10/1205:40EDGAR2Form 8-K - Current report
2023/10/1205:30EDGAR2Form 8-K - Current report
2023/9/2905:24EDGAR2Form RW - Registration Withdrawal Request
2023/9/0905:30EDGAR2Form 8-K - Current report
2023/9/0805:30EDGAR2Form 8-K - Current report
2023/8/1421:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:31EDGAR2Form 8-K - Current report
2023/8/1105:15GLOBEOpGen Reports Second Quarter 2023 Financial Results and..
2023/8/0720:30GLOBEOpGen’s Subsidiary Ares Genetics Releases New Features to..
2023/8/0321:00GLOBEOpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
2023/8/0320:30GLOBEOpGen to Provide Business Update and Financial Results for..
2023/8/0122:40EDGAR2Form DEF 14A - Other definitive proxy statements
2023/7/2205:55EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/7/1920:30GLOBEOpGen’s Subsidiary Curetis Meets Milestones of Extended and..
2023/7/1505:30EDGAR2Form S-1 - General form for registration of securities under..
2023/7/0605:30EDGAR2Form 8-K - Current report
2023/7/0105:30EDGAR2Form 8-K - Current report
2023/6/2620:30GLOBEOpGen Subsidiary Ares Genetics Successfully Maintains Key..
2023/6/2220:30GLOBEOpGen’s Subsidiary Curetis Receives Batch of Ten New..
2023/6/2020:30GLOBEOpGen Presents Unyvero Urinary Tract Infection Panel Trial..
2023/5/1605:15GLOBEOpGen Reports First Quarter 2023 Financial Results and..
2023/5/0820:30GLOBEOpGen to Provide Business Update and Financial Results for..
2023/5/0505:30GLOBEOpGen Announces Closing of $3.5 Million Public Offering
2023/5/0210:00GLOBEOpGen Announces Pricing of $3.5 Million Public Offering

最近閲覧した銘柄

Delayed Upgrade Clock